Antigen Affinity Purified Polyclonal Antibodies

Anti-Murine RANTES (CCL5)

0 ReviewsSubmit a Review

Product Details

Catalogue Number: 500-P118
Description:
Anti-Murine RANTES (CCL5)
 

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant mRANTES. Anti-Murine RANTES specific antibody was purified by affinity chromatography employing immobilized mRANTES matrix.

Immunogen: E.coli derived Recombinant Murine RANTES (CCL5) (PeproTech catalog# 250-07)

Sandwich ELISA: To detect mRANTES by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Murine RANTES (500-P118Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant mRANTES.

Anti-Murine RANTES (CCL5) Sandwich ELISA Anti-Murine RANTES (CCL5) Sandwich ELISA

Western Blot: To detect mRANTES by Western Blot analysis this antibody can be used at a concentration of 0.1-0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant mRANTES is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.

Anti-Murine RANTES (CCL5) Western Blot Reduced Anti-Murine RANTES (CCL5) Western Blot Unreduced Anti-Murine RANTES (CCL5) Western Blot Reduced Anti-Murine RANTES (CCL5) Western Blot Unreduced

Note:

Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information.

crossreactivity:
Country Of Origin: USA

Not for human use.

Research Interest

product.subtitle.recentcitations

First Author
Sobecki, M
Title
NK cells in hypoxic skin mediate a trade-off between wound healing and antibacterial defence
Citation
Nature Communications; 12(1) pg4700
PubMed Id
First Author
Peterson, L W
Title
Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis.
Citation
Journal of immunology (Baltimore, Md. : 1950); 197(10) pg4110-4117
PubMed Id
First Author
Cambien, B
Title
CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma.
Citation
PLoS ONE; 6(12) pge28842
PubMed Id